108 BioCapital Growth Fund, LP — Form D
108 BioCapital Growth Fund, LP of CAMANA BAY, E9, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2026-02-04. The offering totals $10.8M, of which $10.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-02-04
- Form: D
- Accession: 0002109243-26-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b
- Total offering: $10.8M
- Amount sold: $10.8M
- Minimum investment: $250K
- Investors: 10
- Date of first sale: 2025-10-27
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-572348
Issuer
- Name: 108 BioCapital Growth Fund, LP
- CIK: 0002109243
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2025
- Address: 72 MARKET STREET, SUITE 2206, CAMANA BAY, E9, KY1-1204
- Phone: 908-966-3584
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| * 108 BioCapital, LLC | Executive Officer | Danbury, CT |
| * 108 Bio GP, LLC | Executive Officer | Danbury, CT |
| Sasha Bakhru | Executive Officer | Danbury, CT |
| Shom Jagtiani | Executive Officer | Danbury, CT |
| Steve Ward | Executive Officer | Danbury, CT |
More